SCHEMBL7550486

SCHEMBL7550486

N#CC1CCN(CCn2cc(-c3cncc(-c4cccc(Cl)c4)c3)c3ccc(Cl)cc32)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.44
FLT1 P17948 3/20 0.43
FLT4 P35916 3/20 0.43
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MAOA P21397 1/20 0.35
RPS6KB1 P23443 2/20 0.35
AKT1 P31749 2/20 0.35
PIM1 P11309 2/20 0.35
NFATC1 O95644 2/20 0.34
GSK3B P49841 2/20 0.34
DYRK1A Q13627 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7550379 0.94 KDR (0.47) KDRFLT1FLT4CYP11B1CYP11B2
SCHEMBL7548831 0.93 KDR (0.44) KDRFLT1FLT4GRIN1GRIN2B
SCHEMBL7555006 0.93 KDR (0.52) KDRFLT1FLT4GRIN1GRIN2B
SCHEMBL7551299 0.92 KDR (0.44) KDRFLT1FLT4CYP11B1CYP11B2
SCHEMBL7547052 0.91 KDR (0.40) KDRFLT1FLT4CYP11B1CYP11B2
SCHEMBL7976012 0.87 KDR (0.59) KDRFLT1FLT4RPS6KB1AKT1
SCHEMBL7552023 0.87 KDR (0.40) KDRFLT1FLT4GRIN1GRIN2B
SCHEMBL7509366 0.86 KDR (0.47) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7555476 0.86 KDR (0.58) KDRFLT1FLT4GRIN1GRIN2B
SCHEMBL7549993 0.86 KDR (0.40) KDRFLT1FLT4GSK3BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed